Kisspeptin, a neuropeptide, offers potential benefits for treating low sexual desire (hypoactive sexual desire disorder or HSDD) in both men and women, and potentially other reproductive disorders. It has been shown to enhance sexual brain processing, increase penile tumescence in men, and improve measures of sexual desire and arousal.

Potential benefits include:

• Enhanced Sexual Brain Processing: Kisspeptin administration has been shown to modulate brain activity in key areas associated with sexual processing, leading to improved responses to sexual stimuli.
• Increased Penile Tumescence: Studies have demonstrated that kisspeptin increases penile tumescencein men with HSDD, suggesting potential for improved sexual arousal.
• Improved Measures of Sexual Desire and Arousal: Kisspeptin has been associated with increases in participant-reported happiness and flushing about sex.
• Stimulation of Gonadotropin Release: Kisspeptin can stimulate the release of LH and FSH, which are important for reproductivefunction.
• Potential for Treating Other Reproductive Disorders: Kisspeptin's role in the HPG axis suggests it may be a potential therapeutic target for disorders like infertility.

* Kisspeptin injections can enhance sexual brain processing and increase sexual desire and arousal in both men and women, particularly those with low libido or hypoactive sexual desire disorder (HSDD). Injections can also improve brain activity in key regions related to attraction and arousal, potentially leading to a feeling of “more sexy” or increased happiness about sex.